Evidence map›Paper›PMID 28453460›Full record

ArticleCancer biomarkers : section A of Disease markers2017

Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway.

Na Yang, Yan-Jun Qu, Yan Cheng, Tian Liang, Mei-Na Zhang, Dan Zhang, Li-Na Dong, Xiao-Wei Wang, Guang-Mei Zhang

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. GPX8Oncogene · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Na YangDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Yan-Jun QuDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Yan ChengDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Tian LiangDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Mei-Na ZhangDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Dan ZhangDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Li-Na DongDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Xiao-Wei WangDepartment of Gynecological and Obstetric Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Guang-Mei ZhangDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study is to explore the role of tunicamycin-induced endoplasmic reticulum stress (ERS) in human ovarian cancer (OC) SKOV3 cells proliferation, migration and invasion by modulating the activity of PI3K/AKT/mTOR pathway.

methodsThe collected human OC SKOV3 cells were randomly separated into three groups: The control group, the Tun group (treated with tunicamycin to induce ERS) and the CHOP-si group (transfected with CHOP-siRNA before tunicamycin treatment). CCK-8 method was applied for testing cell proliferation, while flow cytometry was conducted to detect cell apoptosis. Scratch test and Transwell test were used to determine the level of cell migration and invasion, respectively. Western blotting was performed to determine the related proteins expressions in ERS and PI3K/AKT/mTOR pathway.

resultsThe cell survival rate in the Tun group was enhanced than that in the CHOP-si group, both of which were declined with the passage of time. The cell apoptosis rate in the Tun group was increased compared to the CHOP-si group, both of which were significantly elevated. The horizontal migration distance and the number of invasive cells in the Tun and CHOP-si groups were inhibited; however, the horizontal migration distance and the number of invasive cells in the CHOP-si group were enhanced than that in the Tun group. In comparison with the control group, the expressions of CHOP and TRB3 were increased in the Tun group but decreased in the CHOP-si group. The PI3K, p-AKT and p-mTOR expressions were remarkably declined in the Tun group than those in the control group (P< 0.05).

conclusionThe study provides strong evidence that tunicamycin-induced ERS induces the apoptosis of human OC SKOV3 cells through inhibiting PI3K/AKT/mTOR signaling pathway.

Indexed as

Cell Line, TumorCell MovementCell ProliferationEndoplasmic Reticulum StressFemaleHumansOvarian NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAKTEndoplasmic reticulum stressmTOR signaling pathwayovarian cancerPI3KSKOV3 cells

Identifiers

PMID28453460
PMCPMC13020726
OpenAlexW2608636746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.